Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of Phase 3 trials - Ratner, R; Gough, S CL; Mathieu, C (Diabetes, Obesity and Metabolism, 2013)
et al.